Myopia Treatment Devices Market Report 2025

This Myopia Treatment Devices market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The myopia treatment devices market size has grown strongly in recent years. It will grow from $6.88 billion in 2024 to $7.53 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth during the historical period can be attributed to factors such as government health initiatives, increased research and development, improved patient education, rising disposable incomes, and a growing focus on pediatric eye care.

The myopia treatment devices market size is expected to see strong growth in the next few years. It will grow to $10.7 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The anticipated growth in the forecast period is driven by the expansion of telemedicine services, advancements in gene therapy, the growth of myopia control programs, improvements in surgical techniques, and the integration of artificial intelligence (AI) in diagnostics. Key trends expected during this period include progress in refractive surgery, solutions for digital eye strain, advanced contact lenses, laser refractive surgery, and the development of biosensors for eye health.

The growing prevalence of eye diseases is expected to drive the expansion of the myopia treatment devices market. Eye diseases encompass a wide range of conditions that affect the eye’s structure or function, potentially leading to vision impairment. The rise in these diseases can be attributed to factors such as aging populations, increased screen time, lifestyle changes, and heightened exposure to environmental pollutants. Myopia treatment devices assist in managing these conditions by slowing myopia progression, enhancing visual clarity, and reducing the risk of complications, offering a proactive approach to maintaining eye health and improving the quality of life for those affected. For example, in May 2024, the Centers for Disease Control and Prevention (CDC) reported that 17.2% of Americans aged 40 and above, approximately 20.5 million individuals, will have cataracts in at least one eye, with this figure projected to exceed 30 million by 2028. This increasing incidence of eye diseases is driving the growth of the myopia treatment devices market.

Companies in the myopia treatment devices sector are focusing on technological innovation to enhance their competitive edge and meet the growing demand for effective, user-friendly treatments. One such innovation is the overnight therapeutic lens, a type of contact lens worn during sleep to provide temporary vision correction for conditions such as myopia, astigmatism, or presbyopia. For example, in January 2022, Johnson & Johnson Vision introduced the ACUVUE Abiliti, a new line of myopia management products aimed at addressing the rising myopia rates in children. The ACUVUE Abiliti 1-Day Soft Therapeutic Lenses are designed for children aged 7 to 12 and help slow the progression of myopia. These daily-wear lenses have been shown to reduce axial elongation by an average of 0.105 mm over six months, which helps decrease the long-term risks associated with high myopia, potentially preventing severe vision problems in the future.

In January 2023, CooperVision Inc., a US-based contact lens manufacturer, acquired SynergEyes Inc. for an undisclosed amount. This acquisition allows CooperVision to expand its specialty contact lens portfolio, particularly by incorporating SynergEyes' hybrid lens technologies, which are used in the treatment of keratoconus and irregular corneas. SynergEyes is a US-based developer specializing in hybrid contact lenses, including those for myopia treatment.

Major players in the myopia treatment devices market are EssilorLuxottica S.A., Carl Zeiss Meditec AG, Alcon Inc., Hoya Corporation, Bausch & Lomb Incorporated, CooperVision Inc., Johnson & Johnson Vision Care Inc., Topcon Corporation, Menicon Co. Ltd., STAAR Surgical Company, Paragon Vision Sciences Inc., Ziemer Ophthalmic Systems AG, Euclid Systems Corporation, Art Optical Contact Lens Inc., Schwind Eye Tech Solutions GmbH, Kubota Pharmaceutical Holdings Co Ltd., Visioneering Technologies Inc., Eyerising International, Nidek Co Ltd., and Falco Linsen AG.

North America was the largest region in the myopia treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in myopia treatment devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the myopia treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Myopia treatment devices are a range of tools and technologies designed to manage or correct myopia (nearsightedness). These devices employ advanced techniques, such as reshaping the cornea with ortho-K lenses or using atropine drops, to slow myopia progression and improve vision without the need for continuous corrective eyewear.

The main types of myopia treatment devices include eyeglasses, contact lenses, ortho-K lenses, phakic intraocular lenses, and excimer laser refractive surgery devices. Eyeglasses are wearable optical devices created to correct vision issues or protect the eyes. Treatment options include corrective lenses, laser eye surgery, and lens implant surgery, with end users including hospitals, clinics, ophthalmic centers, retail stores, and online platforms.

The myopia treatment devices market research report is one of a series of new reports that provides myopia treatment devices market statistics, including myopia treatment devices industry global market size, regional shares, competitors with a myopia treatment devices market share, detailed myopia treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the myopia treatment devices industry. This myopia treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The myopia treatment devices market consists of sales of orthokeratology (ortho-k) lenses, myopia control contact lenses, atropine eye drops, smart glasses, and peripheral defocus lenses. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.